The future of
single-domain antibodies


As part of a collaboration under FP7-HEALTH AgedBrainSYSBio program, Hybrigenics selected and validated anti-Fyn VHH nanobodies working inside cells - intrabodies. Our lab currently explores these very exciting novel tools in primary neurons. — Prof. Michel Simmoneau (Centre for Psychiatry and Neuroscience, Paris, France) - Europe

Back to testimonials

Back to Top